Apotex looking to sell about $1 billion in shares in initial public offering

Apotex workers are shown in Toronto on Friday, April 9, 2021. THE CANADIAN PRESS/Nathan Denette

TORONTO — Drug company Apotex Health Corp. says it is looking to sell about $1 billion worth of shares in its initial public offering.

The company says it expects to sell between 41.7 million and 50 million shares at a price between $20 and $24 per share.

The plan includes the sale of between 35.4 million and 42.5 million shares in a treasury offering by the company valued at a total of about $850 million.

It also includes a secondary offering of between 6.25 million and 7.5 million shares by certain shareholders valued at a total of about $150 million.

The selling shareholders are also expected to grant an over-allotment option to the underwriters for up to an additional 6.25 million to 7.5 million shares at the offering price

Apotex, which has applied to list the shares on the Toronto Stock Exchange, has a broad portfolio of generic drugs and consumer health products.

This report by The Canadian Press was first published June 1, 2026.

The Canadian Press